Sharer stands down in Amgen transition; Danish biotech announces deep staffing cuts; UK readies £250M life sciences initiative;

Biotech News

 @FierceBiotech: Vitamin D boosts TB shot as cancer therapy. More | Follow @FierceBiotech

 @RyanMFierce: Pfizer brings Lipitor brand to mobile app stores. Report | Follow @RyanMFierce

 @JohnCFierce: So Globe's verastem coverage says best-case scenario is start trials in a year, products available in four. A three-year cancer stem cell program? Ha. | Follow @JohnCFierce

> It's the end of an era at Amgen ($AMGN) as Kevin Sharer steps down as CEO and hands the reins of the big biotech to Bob Bradway. Story

> Denmark's Veloxis is circling the wagons around its lead therapy to prevent organ rejection. The biotech says it plans to cut anywhere from 25 to 30 staffers from its 60-person employee roster. Release

> U.K. science minister David Willets is expected to announce £250 million in fresh support for the country's life sciences industry today. Story

> Bloomberg makes the case that GlaxoSmithKline's ($GSK) propensity for buying biotechs it collaborates with points to possible M&A moves in the future. Report

> Blueprint Medicines says that Fidelity Biosciences has joined the lineup of venture groups involved in its $40 M A round announced earlier. Stephen Knight, the managing partner at Fidelity, has joined the Blueprint board. Release

Pharma News

 @FiercePharma: Another German drugmaker in takeover talks: Riemser may pick shortlist by next week--BloombergStory | Follow @FiercePharma

> New Teva chief slashes sales forecast by $1B. News

> EU antitrust officials probe parallel trade. Article

> Securities watchdogs reportedly probe Shanghai Pharma deals. Item

> FDA panel draws blood in Xarelto's bid for new use. Report

Medical Device News

 @FierceMedDev: HeartWare gained expanded European approval for its HVAD implant. Trials continue in the U.S., however. Story | Follow @FierceMedDev

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Orrin Hatch pulls device tax repeal amendment from user fee bill. Report

> Once spectrum is approved, wireless patient monitors still face obstacles. Article

> Alere recalls thousands of cardiac diagnostic tests. More

> House Republicans push for tax-repeal vote. Item

Pharma Manufacturing News

 @EricPFierce: FDA to Crescendo: We told you so. Marshals seize steroid gel from California firm that was selling unapproved drug. Report | Follow @EricPFierce

> FDA may impose more QA checks on heparin makers. Story

> Recipharm snags $114 million loan, says its shopping. Article

> Heart attack test alert from Alere. More

> FDA takes aim at Spanish drugmaker. Item

CRO News

 @NesaNFierce: What should a CDMO do with 90 million Euros? Buy more CDMOs, as Recipharm announced it will do. Article | Follow @NesaNFierce

> SGS picks up testing company Vitrology for an undisclosed fee. News

> Pfizer's David Simmons joins PPD as new CEO and chairman. Story

> PRA expands European ops with new Dutch and British offices. More

> Quintiles survey shows U.S. and U.K. payers want to improve R&D with increased involvement. Item

Vaccines News

> Wishing you a happy HIV Vaccine Awareness Day. Report

> Vitamin D boosts TB shot as cancer therapy. Article

> DNA vaccine swats TB and HIV. News

> HIV vaccine carries its own adjuvant into clinical trials. Story

And Finally... A new study indicates that certain "obesity genes" may influence the foods that are chosen by people who are overweight. More